• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prevalence and outcomes of stent thrombosis with in-stent calcified nodules: substudy from the REAL-ST registry.支架内钙化结节所致支架血栓形成的患病率和结局:REAL-ST 注册研究的亚组研究。
EuroIntervention. 2022 Oct 21;18(9):749-758. doi: 10.4244/EIJ-D-21-00976.
2
Risk Factors and Outcomes of Recurrent Drug-Eluting Stent Thrombosis: Insights From the REAL-ST Registry.复发性药物洗脱支架血栓形成的风险因素和结果:来自 REAL-ST 注册研究的见解。
J Am Heart Assoc. 2021 May 4;10(9):e018972. doi: 10.1161/JAHA.120.018972. Epub 2021 Apr 17.
3
Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.裸金属支架、第一代药物洗脱支架和第二代药物洗脱支架的支架血栓形成风险:来自 18334 名患者的注册研究结果。
JACC Cardiovasc Interv. 2013 Dec;6(12):1267-74. doi: 10.1016/j.jcin.2013.06.015.
4
Five-Year Clinical Outcomes After Drug-Eluting Stent Implantation Following Rotational Atherectomy for Heavily Calcified Lesions.旋磨术治疗重度钙化病变后置入药物洗脱支架 5 年的临床结果。
Circ J. 2018 Mar 23;82(4):983-991. doi: 10.1253/circj.CJ-17-0564. Epub 2017 Sep 9.
5
Risk Factors and Long-Term Clinical Outcomes of Second-Generation Drug-Eluting Stent Thrombosis.第二代药物洗脱支架血栓形成的危险因素和长期临床结局。
Circ Cardiovasc Interv. 2019 Jun;12(6):e007822. doi: 10.1161/CIRCINTERVENTIONS.119.007822. Epub 2019 Jun 10.
6
Comparison of Efficacy and Safety between First- and Second-Generation Drug-Eluting Stents in Patients with Acute Coronary Syndrome.比较急性冠状动脉综合征患者使用第一代和第二代药物洗脱支架的疗效和安全性。
Chin Med J (Engl). 2018 Jun 20;131(12):1397-1405. doi: 10.4103/0366-6999.233959.
7
Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).晚期和极晚期药物洗脱支架血栓形成的相关因素和结果:DESERT(国际药物洗脱支架血栓形成事件注册研究)的结果。
JACC Cardiovasc Interv. 2014 Oct;7(10):1093-102. doi: 10.1016/j.jcin.2014.04.017. Epub 2014 Sep 17.
8
Stent thrombosis with second- versus first-generation drug-eluting stents in real-world percutaneous coronary intervention: analysis of 3806 consecutive procedures from a large-volume single-center prospective registry.真实世界经皮冠状动脉介入治疗中第二代与第一代药物洗脱支架的支架内血栓形成:来自一个大容量单中心前瞻性注册研究的3806例连续手术分析
J Invasive Cardiol. 2013 Jul;25(7):330-6.
9
Clinical impact of calcified nodule in patients with heavily calcified lesions requiring rotational atherectomy.旋磨术治疗重度钙化病变患者中钙化结节的临床影响。
Catheter Cardiovasc Interv. 2021 Jan 1;97(1):10-19. doi: 10.1002/ccd.28896. Epub 2020 Apr 7.
10
Everolimus-eluting stents versus sirolimus- or paclitaxel-eluting stents: two-year results from the Guthrie Health Off-Label Stent (GHOST) registry.依维莫司洗脱支架与西罗莫司或紫杉醇洗脱支架的比较:Guthrie 卫生保健非适应证支架(GHOST)注册研究的 2 年结果。
J Interv Cardiol. 2013 Apr;26(2):153-62. doi: 10.1111/j.1540-8183.2013.12016.x. Epub 2013 Jan 31.

引用本文的文献

1
Successful management of a calcified coronary nodule with intravenous lithotripsy: a case report and review of literature.静脉内碎石术成功治疗钙化性冠状动脉结节:一例报告并文献复习
J Med Case Rep. 2025 Jun 18;19(1):282. doi: 10.1186/s13256-025-05341-9.
2
An effective treatment for repeated coronary in-stent restenosis using rotational atherectomy after aggressive wire penetration through the calcified nodule: a case report.经积极钢丝穿透钙化结节后使用旋磨术治疗反复冠状动脉支架内再狭窄:一例报告
Eur Heart J Case Rep. 2025 Jun 2;9(6):ytaf268. doi: 10.1093/ehjcr/ytaf268. eCollection 2025 Jun.
3
Covered stent implantation for calcified nodule to physically hinder its protrusion causing restenosis: a case report.覆膜支架植入治疗钙化结节以物理性阻碍其突出导致再狭窄:一例报告
Cardiovasc Diagn Ther. 2024 Oct 31;14(5):974-981. doi: 10.21037/cdt-24-216. Epub 2024 Oct 22.
4
Lifetime management of severely calcified coronary lesions: the treatment algorithm focused on the shape of calcification.严重钙化冠状动脉病变的终生管理:聚焦于钙化形态的治疗策略。
Cardiovasc Interv Ther. 2023 Oct;38(4):375-380. doi: 10.1007/s12928-023-00950-x. Epub 2023 Aug 5.
5
Very Early Progression of an In-Stent Calcified Nodule 2 Weeks After Drug-Eluting Stent Implantation in the Calcified Lesion.药物洗脱支架植入钙化病变后2周内支架内钙化结节的极早期进展
CJC Open. 2022 Jul 9;4(9):820-822. doi: 10.1016/j.cjco.2022.07.001. eCollection 2022 Sep.

本文引用的文献

1
Risk Factors and Outcomes of Recurrent Drug-Eluting Stent Thrombosis: Insights From the REAL-ST Registry.复发性药物洗脱支架血栓形成的风险因素和结果:来自 REAL-ST 注册研究的见解。
J Am Heart Assoc. 2021 May 4;10(9):e018972. doi: 10.1161/JAHA.120.018972. Epub 2021 Apr 17.
2
Cardiac outcomes in patients with acute coronary syndrome attributable to calcified nodule.归因于钙化结节的急性冠状动脉综合征患者的心脏结局。
Atherosclerosis. 2021 Feb;318:70-75. doi: 10.1016/j.atherosclerosis.2020.11.005. Epub 2020 Nov 11.
3
Formation of Calcified Nodule as a Cause of Early In-Stent Restenosis in Patients Undergoing Dialysis.透析患者钙化结节形成是早期支架内再狭窄的原因。
J Am Heart Assoc. 2020 Oct 20;9(19):e016595. doi: 10.1161/JAHA.120.016595. Epub 2020 Sep 23.
4
Outcomes After First- Versus Second-Generation Drug-Eluting Stent Thrombosis (from the REAL-ST Registry).第一代与第二代药物洗脱支架血栓形成后的结局(来自 REAL-ST 注册研究)。
Am J Cardiol. 2020 Oct 1;132:52-58. doi: 10.1016/j.amjcard.2020.07.011. Epub 2020 Jul 14.
5
The frequency and clinical characteristics of in-stent restenosis due to calcified nodule development after coronary stent implantation.冠状动脉支架置入术后钙化结节发展导致支架内再狭窄的频率及临床特征。
Int J Cardiovasc Imaging. 2021 Jan;37(1):15-23. doi: 10.1007/s10554-020-01952-z. Epub 2020 Jul 30.
6
Optical coherence tomography characteristics of in-stent restenosis after drug-eluting stent implantation: a novel classification and its clinical significance.药物洗脱支架植入术后支架内再狭窄的光学相干断层扫描特征:一种新分类及其临床意义。
Heart Vessels. 2020 Jan;35(1):38-45. doi: 10.1007/s00380-019-01461-7. Epub 2019 Jun 27.
7
Risk Factors and Long-Term Clinical Outcomes of Second-Generation Drug-Eluting Stent Thrombosis.第二代药物洗脱支架血栓形成的危险因素和长期临床结局。
Circ Cardiovasc Interv. 2019 Jun;12(6):e007822. doi: 10.1161/CIRCINTERVENTIONS.119.007822. Epub 2019 Jun 10.
8
Prevalence, Predictors, and Clinical Presentation of a Calcified Nodule as Assessed by Optical Coherence Tomography.光学相干断层扫描评估的钙化结节的患病率、预测因素和临床表现。
JACC Cardiovasc Imaging. 2017 Aug;10(8):883-891. doi: 10.1016/j.jcmg.2017.05.013.
9
Calcified Nodule: An Early and Late Cause of In-Stent Failure.钙化结节:支架内失败的早期和晚期原因
JACC Cardiovasc Interv. 2016 Jul 11;9(13):e125-6. doi: 10.1016/j.jcin.2016.03.036. Epub 2016 Jun 15.
10
The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial.在 ABSORB II 试验中,生物可吸收依维莫司洗脱支架和金属依维莫司洗脱支架的术后对称性、扩张和偏心对临床结果的影响。
JACC Cardiovasc Interv. 2016 Jun 27;9(12):1231-1242. doi: 10.1016/j.jcin.2016.03.027. Epub 2016 Jun 1.

支架内钙化结节所致支架血栓形成的患病率和结局:REAL-ST 注册研究的亚组研究。

Prevalence and outcomes of stent thrombosis with in-stent calcified nodules: substudy from the REAL-ST registry.

机构信息

Division of Cardiology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.

Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.

出版信息

EuroIntervention. 2022 Oct 21;18(9):749-758. doi: 10.4244/EIJ-D-21-00976.

DOI:10.4244/EIJ-D-21-00976
PMID:35389345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10241266/
Abstract

BACKGROUND

The relationship between in-stent calcified nodules (IS-CN) and second-generation drug-eluting stent (G2-DES) stent thrombosis (ST) remains uncertain.

AIMS

We aimed to evaluate the prevalence, clinical demographic and long-term clinical outcomes after G2-DES ST with IS-CN.

METHODS

The prespecified substudy of the REAL-ST registry (a retrospective, multicentre registry of patients with definite ST after first- and G2-DES implantation) enrolled patients who experienced definite G2-DES ST and who underwent pre-intervention intravascular ultrasound imaging at index ST events.

RESULTS

IS-CN was observed in 15 out of 118 (13%) definite G2-DES ST cases. The multiple logistic regression model demonstrated that haemodialysis (odds ratio [OR] 12.27, 95% confidence interval [CI]: 1.56-94.54; p=0.02), proximal or mid-right coronary artery lesions (OR 12.79, 95% CI: 1.78-92.13; p=0.01) and severe calcification (OR 13.01, 95% CI: 1.18-142.94; p=0.04) were independently associated with ST with IS-CN. The cumulative 5-year incidence of target lesion revascularisation (TLR) after ST was significantly higher in the IS-CN group than in the non-IS-CN group (p=0.02). Independent predictors of TLR after the index ST events were female sex (hazard ratio [HR] 3.05, 95% CI: 1.20-7.74; p=0.02), diabetes mellitus (HR 3.26, 95% CI: 1.26-8.41; p=0.01) and IS-CN (HR 3.07, 95% CI: 1.16-8.14; p=0.02).

CONCLUSIONS

IS-CN may be one of the underlying mechanisms of G2-DES ST. Notably, IS-CN was associated with a higher TLR rate after the index ST events, suggesting the need for careful clinical follow-up of ST patients with IS-CN.

摘要

背景

支架内钙化结节(IS-CN)与第二代药物洗脱支架(G2-DES)支架血栓(ST)之间的关系仍不确定。

目的

我们旨在评估 G2-DES ST 合并 IS-CN 的患病率、临床人口统计学和长期临床结局。

方法

REAL-ST 注册研究(一项回顾性、多中心的第一代和第二代药物洗脱支架植入后明确 ST 患者的注册研究)的预设亚研究纳入了发生明确 G2-DES ST 且在 ST 事件时进行了术前血管内超声成像的患者。

结果

在 118 例明确的 G2-DES ST 病例中,有 15 例(13%)观察到 IS-CN。多变量逻辑回归模型表明,血液透析(比值比[OR] 12.27,95%置信区间[CI]:1.56-94.54;p=0.02)、近端或中段右冠状动脉病变(OR 12.79,95%CI:1.78-92.13;p=0.01)和严重钙化(OR 13.01,95%CI:1.18-142.94;p=0.04)与 IS-CN 合并 ST 独立相关。ST 后 5 年靶病变血运重建(TLR)的累积发生率在 IS-CN 组明显高于非 IS-CN 组(p=0.02)。ST 后 TLR 的独立预测因素为女性(风险比[HR] 3.05,95%CI:1.20-7.74;p=0.02)、糖尿病(HR 3.26,95%CI:1.26-8.41;p=0.01)和 IS-CN(HR 3.07,95%CI:1.16-8.14;p=0.02)。

结论

IS-CN 可能是 G2-DES ST 的潜在机制之一。值得注意的是,IS-CN 与 ST 后 TLR 率较高相关,这表明需要对 IS-CN 合并 ST 的患者进行仔细的临床随访。